#	Pagina
attuale pagina	/open-h2020/projects/209468/index.html

Opendata, web and dolomites

DO-IT SIGNED

Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

DO-IT project word cloud

Explore the words cloud of the DO-IT project. It provides you a very rough idea of what is the project "DO-IT" about.

treatments action disease market consent standards purposes line overarching act policy brings starting patients privacy care transformative gt regulators spectrum groups healthcare forms academia sustainability pivotal samples industry adoption synthesise shared engagement patient health exchange platform innovative supporting materials payers integrate transformation quality outcomes icfs stakeholders transparency accessible ensures diffusion consistency data single paradigm easily personal informed minimum providers bd4bo pharmaceutical communication strategy makers accordingly individual shift big stakeholder innovation csa biological medicines consideration point human

Project "DO-IT" data sheet

The following table provides information about the project.

Coordinator	LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE Organization address address: Houghton Street 1 city: LONDON postcode: WC2A 2AE website: www.lse.ac.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	United Kingdom [UK]
Project website	http://www.bd4bo.eu
Total cost	7˙191˙755 €
EC max contribution	3˙549˙833 € (49%)
Programme	1. H2020-EU.3.1.7. (Innovative Medicines Initiative 2 (IMI2))
Code Call	H2020-JTI-IMI2-2015-07-two-stage
Funding Scheme	IMI2-CSA
Starting year	2017
Duration (year-month-day)	from 2017-02-01 to 2019-01-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE Organization address address: Houghton Street 1 city: LONDON postcode: WC2A 2AE website: www.lse.ac.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (LONDON)	coordinator	1˙263˙850.00
2	IHE, INSTITUTET FOR HALSO- OCH SJUKVARDSEKONOMI AKTIEBOLAG IHE, INSTITUTET FOR HALSO- OCH SJUKVARDSEKONOMI AKTIEBOLAG Organization address address: PO BOX 2127 city: LUND postcode: 220 02 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	SE (LUND)	participant	453˙440.00
3	SEMMELWEIS EGYETEM SEMMELWEIS EGYETEM Organization address address: ULLOI UTCA 26 city: BUDAPEST postcode: 1085 website: www.sote.hu contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	HU (BUDAPEST)	participant	359˙918.00
4	NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Organization address address: LEVEL 1A CITY TOWER PICCADILLY PLAZA city: MANCHESTER postcode: M1 4BT website: www.nice.org.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (MANCHESTER)	participant	298˙788.00
5	TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV Organization address address: CHARLOTTENSTRASSE 42 ECKE DOROTHEENSTRASSE city: BERLIN postcode: 10117 website: www.tmf-ev.de contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (BERLIN)	participant	231˙190.00
6	FOLKEHELSEINSTITUTTET FOLKEHELSEINSTITUTTET Organization address address: LOVISENBERGGATA 8 city: OSLO postcode: 456 website: www.fhi.no contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NO (OSLO)	participant	186˙240.00
7	IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE Organization address address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD city: LONDON postcode: SW7 2AZ website: http://www.imperial.ac.uk/ contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (LONDON)	participant	169˙776.00
8	TANDVARDS-OCH LAKEMEDELSFORMANSVERKET TANDVARDS-OCH LAKEMEDELSFORMANSVERKET Organization address address: FLEMINGGATAN 7 city: STOCKHOLM postcode: 10422 website: www.tlv.se contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	SE (STOCKHOLM)	participant	149˙000.00
9	THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL Organization address address: RUE AUGUSTE LAMBIOTTE 144/8 city: BRUXELLES postcode: 1030 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	BE (BRUXELLES)	participant	120˙745.00
10	UNIVERSITA COMMERCIALE LUIGI BOCCONI UNIVERSITA COMMERCIALE LUIGI BOCCONI Organization address address: VIA SARFATTI 25 city: MILANO postcode: 20136 website: www.unibocconi.it contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (MILANO)	participant	119˙921.00
11	EUROPEAN CANCER PATIENT COALITION EUROPEAN CANCER PATIENT COALITION Organization address address: RUE MONTOYER 40 city: BRUXELLES postcode: 1000 website: www.ecpc-online.org contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	BE (BRUXELLES)	participant	100˙644.00
12	INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE Organization address address: RUE DE TOLBIAC 101 city: PARIS postcode: 75654 website: www.inserm.fr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (PARIS)	participant	96˙321.00
13	AMGEN AMGEN Organization address address: Avenue Ariane 5 city: Bruxelles postcode: 1200 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	BE (Bruxelles)	participant	0.00
14	ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA Organization address address: CALLE MARIA DE MOLINA 54 city: MADRID postcode: 28006 website: www.farmaindustria.es contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (MADRID)	participant	0.00
15	BAYER AKTIENGESELLSCHAFT BAYER AKTIENGESELLSCHAFT Organization address address: KAISER-WILHEM-ALLEE 1 city: Leverkusen postcode: 51373 website: http://pharma.bayer.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (Leverkusen)	participant	0.00
16	BOEHRINGER INGELHEIM INTERNATIONALGMBH BOEHRINGER INGELHEIM INTERNATIONALGMBH Organization address address: BINGER STRASSE city: INGELHEIM postcode: 55218 website: www.boehringerâ€ingelheim.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (INGELHEIM)	participant	0.00
17	CELGENE MANAGEMENT SARL CELGENE MANAGEMENT SARL Organization address address: ROUTE DE PERREUX 1 city: BOUDRY postcode: 2017 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	CH (BOUDRY)	participant	0.00
18	Eli Lilly and Company Limited Eli Lilly and Company Limited Organization address address: Lilly House, Priestley Road city: Basingstoke postcode: RG24 9NL website: www.lilly.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (Basingstoke)	participant	0.00
19	F. HOFFMANN-LA ROCHE AG F. HOFFMANN-LA ROCHE AG Organization address address: GRENZACHERSTRASSE 124 city: BASEL postcode: 4070 website: www.roche.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	CH (BASEL)	participant	0.00
20	FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES Organization address address: RUE DU TRONE 108/1 city: BRUXELLES postcode: 1050 website: www.efpia.eu contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	BE (BRUXELLES)	participant	0.00
21	GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. Organization address address: Great West Road 980 city: BRENTFORD postcode: TW89GS website: www.gsk.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (BRENTFORD)	participant	0.00
22	HEALTH IQ LIMITED HEALTH IQ LIMITED Organization address address: E1 BUSINESS CENTRE 3RD FLOOR 7 WHITECHAPEL ROAD city: LONDON postcode: E1 1DU website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (LONDON)	participant	0.00
23	INSTITUT DE RECHERCHES INTERNATIONALES SERVIER INSTITUT DE RECHERCHES INTERNATIONALES SERVIER Organization address address: RUE CARNOT 50 city: SURESNES postcode: 92284 website: www.servier.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (SURESNES)	participant	0.00
24	INTERSYSTEMS GMBH INTERSYSTEMS GMBH Organization address address: HILPERTSTRASSE 20 A city: DARMSTADT postcode: 64295 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (DARMSTADT)	participant	0.00
25	JANSSEN PHARMACEUTICA NV JANSSEN PHARMACEUTICA NV Organization address address: TURNHOUTSEWEG 30 city: BEERSE postcode: 2340 website: www.janssenpharmaceutica.be contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	BE (BEERSE)	participant	0.00
26	MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN Organization address address: FRANKFURTER STRASSE 250 city: DARMSTADT postcode: 64293 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (DARMSTADT)	participant	0.00
27	MERCK SHARP & DOHME CORP MERCK SHARP & DOHME CORP Organization address address: ONE MERCK DRIVE city: WHITEHOUSE STATION NJ postcode: 8889 website: www.merck.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	US (WHITEHOUSE STATION NJ)	participant	0.00
28	NOVARTIS PHARMA AG NOVARTIS PHARMA AG Organization address address: LICHTSTRASSE 35 city: BASEL postcode: 4056 website: www.novartis.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	CH (BASEL)	participant	0.00
29	NOVO NORDISK A/S NOVO NORDISK A/S Organization address address: NOVO ALLE 1 city: BAGSVAERD postcode: 2880 website: www.novonordisk.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DK (BAGSVAERD)	participant	0.00
30	PFIZER LIMITED PFIZER LIMITED Organization address address: RAMSGATE ROAD city: SANDWICH postcode: CT13 9NJ website: www.pfizer.co.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (SANDWICH)	participant	0.00
31	SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT Organization address address: Pierre Brossolette 1 city: Chilly Mazarin postcode: 91380 website: www.sanofi-aventis.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (Chilly Mazarin)	participant	0.00
32	STATENS LEGEMIDDELVERK STATENS LEGEMIDDELVERK Organization address address: Grensesvingen 26 city: OSLO postcode: 213 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NO (OSLO)	participant	0.00
33	THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY Organization address address: 105 VICTORIA STREET city: LONDON postcode: SW1E 6QT website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (LONDON)	participant	0.00
34	THE UNIVERSITY OF LIVERPOOL THE UNIVERSITY OF LIVERPOOL Organization address address: BROWNLOW HILL 765 FOUNDATION BUILDING city: LIVERPOOL postcode: L69 7ZX website: www.liverpool.ac.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (LIVERPOOL)	participant	0.00
35	UCB BIOPHARMA SRL UCB BIOPHARMA SRL Organization address address: ALLEE DE LA RECHERCHE 60 city: BRUXELLES postcode: 1070 website: www.ucb.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	BE (BRUXELLES)	participant	0.00
36	VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV Organization address address: HAUSVOGTEIPLATZ 13 city: Berlin postcode: 10117 website: www.vfa.de contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (Berlin)	participant	0.00

Map

Project objective

The overall goal of the Big Data for Better Outcomes (BD4BO) programme is to facilitate the use of ‘big data’ to promote the development of value-based, outcomes-focused healthcare systems in Europe. To fully exploit the transformative potential of big data, consideration will need to be taken of the use of detailed personal and biological information across the spectrum of care delivery, starting from the development of innovative medicines and treatments, to market access and adoption, diffusion, and use in healthcare systems by providers and patients. This paradigm shift requires shared understanding and standards among healthcare stakeholders including patients, providers, payers, regulators, policy makers, pharmaceutical industry, and academia.

OBJECTIVES The proposed Coordination and Support Action (CSA) will establish an enabling platform that brings together these stakeholder groups across the BD4BO programme to ensure quality and consistency of individual projects in line with the overarching programme objective. Our consortium therefore aims to promote the use of big Data for better Outcomes, policy Innovation and healthcare system Transformation (DO->IT). Accordingly, we will: • Define a programme strategy that ensures quality, consistency and sustainability of health outcomes related activities across individual BD4BO projects. • Integrate, synthesise, and manage knowledge from all BD4BO projects, making it easily accessible via a single knowledge exchange platform. • Act as pivotal point of collaboration, stakeholder engagement and communication for all BD4BO projects. • Provide transparency and enable the use of patient health data and human biological samples for research purposes by developing minimum data privacy standards for Informed Consent Forms (ICFs) and supporting materials for use by individual BD4BO disease-specific projects and more widely in the Research and Development (R&D) sector.

Deliverables

List of deliverables.
Narrative: The consortium narrative that communicates the purpose of the BD4BO programme	Documents, reports	2020-04-08 21:28:29
Level 2 Biobanking ICF	Documents, reports	2020-04-08 21:28:28
Continous exchange with external data privacy related stakeholders (DPECs, BD4BO projects, other related data privacy initiatives)	Other	2020-04-08 21:28:28
Run DPEC-R F2F workshop to collect input on critical data privacy topics	Other	2020-04-08 21:28:28
Level 2 Clinical ICF	Documents, reports	2020-04-08 21:28:29
Level 3 Non-Clinical ICF	Documents, reports	2020-04-08 21:28:29
Training Materials for patients and to increase awareness about R&D, and to clarify essential aspects of data privacy laws and regulations in R&D	Documents, reports	2020-04-08 21:28:29
Level 3 Biobanking ICF	Documents, reports	2020-04-08 21:28:29
Level 2 Non-Clinical ICF	Documents, reports	2020-04-08 21:28:28
Explanatory Information on minimum data privacy standards for ICFs for clinical studies, non-clinical studies and biobanking incl. focus groupâ€™ feedback on the Clinical ICF, Non-Clinical ICF and Biobanking ICF	Documents, reports	2020-04-08 21:28:29
DPEC-O F2F workshop to collect input on critical data privacy topics	Other	2020-04-08 21:28:29
Level 1 Clinical ICF based on T4.1.1, T4.2.1 and D4.15	Documents, reports	2020-04-08 21:28:29
Establish unmet â€˜big dataâ€™ data needs of the health care system	Documents, reports	2020-04-08 21:28:28
Set up the infrastructure and maintenance required for the communications and outreach plans; refer to deliverable descriptions for the type of activities that will be implemented	Other	2020-04-08 21:28:28
Level 3 Clinical ICF	Documents, reports	2020-04-08 21:28:28
Establish and coordinate engagement with International Advisory Board (IAB) and Data Protection & Ethics Committee (DPEC)	Other	2020-04-08 21:28:28
Establish Data Privacy and Ethics Committees (DPECs): - Operational-DPEC (DPEC-O) - Regulatory-DPEC (DPEC-R)	Other	2020-04-08 21:28:28
Develop interim/short-term strategic guidance document	Documents, reports	2020-04-08 21:28:28
Summary of the empirical investigation results, including proposal on method in order to integrate survey results	Documents, reports	2020-04-08 21:28:28
Develop a targeted outreach plan for external collaboration with stakeholders	Documents, reports	2020-04-08 21:28:28
Interim guidance document for existing BD4BO projects on approach proposed by the Distributed Data Network working group	Documents, reports	2020-04-08 21:28:28

Take a look to the deliverables list in detail: detailed list of DO-IT deliverables.

Publications

List of publications.
year	authors and title	journal	last update
2017	Michel Van Speybroeck (Janssen), Michael Arend (Bayer), Jeremy Hayter (Pfizer), Joachim Marti (Imperial College London), Anthouny Rowe (Janseen), Jerry Lanfear (Pfizer) Interim guidance document for existing BD4BO projects on approach proposed by the Distributed Data Network working group published pages: , ISSN: , DOI:		2020-04-08
2017	Myriam Drysdale, Marianne Cunningham and Bart Barefoot(GlaxoSmithKline); Fredrik Moen from the Swedish Institute of Health; Tino Melzer (Bayer); Irene Schluender (TMF);Michel Van Speybroeck (Janssen); Michael Arend (Bayer); Jeremy Hayter (Pfizer); Joachim Marti (Imperial College London); Anthony Rowe (Janssen);Jerry Lanfear (Pfizer);Carmen Fenollosa (LSE);LÃ¡szlÃ³ Bencze (Semmelweis University);Heather Stegenga, (NICE);Stephan Korte (Novartis) Interim strategic guidance document published pages: , ISSN: , DOI:		2020-04-08
2017	Maximilian Salcher Connecting the dots: putting big data to work for health systems published pages: 3-6, ISSN: 1356-1030, DOI:	EuroHealth 2017; Vol. 23(1):	2020-04-08
2017	MiklÃ³s SzÃ³cska, Sahan Jayawardana, Carin Smand, Tayyab Salimullah, Catherine Reed and Shahid Hanif Big Data for Better Outcomes: Supporting Health Care System Transformation in Europe published pages: 7-9, ISSN: 1356-1030, DOI:	EuroHealth 2017; Vol. 23(1):	2020-04-08
2018	Ciani O1, Meregaglia M2, Jayawardana S3, Carney C3, Salcher M3, Williamson P41Centre for Research on Health and Social Care Management (CERGAS), Bocconi University, Milan, Italy, 2Bocconi University, Milan, Italy, 3London School of Economics and Political Science, London, UK, 4University of Liverpool, Liverpool, UK CliniCal Core outComes sets in real World data published pages: 112, ISSN: , DOI:	VALUE IN HEALTH Journal	2020-04-08

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DO-IT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DO-IT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.7.)

EBOVAC3 (2018)

Bringing a prophylactic Ebola vaccine to licensure

GNA NOW (2019)

NOVEL GRAM-NEGATIVE ANTIBIOTIC NOW

RespiriTB (2019)

Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors